The Nomination Committee for the Annual General Meeting in 2017
2017-01-23 In accordance with a resolution from the 2016 Annual General Meeting the Nomination Committee shall consist of the Chairman of the Board and one representative for each of the three largest shareholders in terms of voting rights at the end of September 2016. At the end of September 2016, the two largest shareholders were Cadila Pharma and Fåro Capital. The third and fourth largest shareholders have declined to participate in the Nomination Committee. The fifth largest shareholder is Ingemar Kihlström, who is also the Chairman of the Board. For the 2017 Annual General